
|Articles|July 1, 2002
Terbinafine surpasses comparators for clearing onychomycosis
New Orleans - In the treatment of onychomycosis, terbinafine (Lamisil) offers better short-term and long-term efficacy relative to other oral antifungal agents, Bernard J. Cribier, M.D., Ph.D., said at the annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Auricular Acupuncture for Facial Rejuvenation: Results from a Large Real-World Clinical Series
2
Sun Pharma’s Cosibelimab-ipdl (UNLOXCYT) Enters US Market for Advanced CSCC
3
Graham Heap, MBBS, PhD, Discusses Positive Phase 3 Results for Zasocitinib
4
Lebrikizumab Enters Late-Stage Testing for Nummular Eczema
5


















